AstraZeneca-Oxford's coronavirus vaccine trials resume in Brazil

AstraZeneca paused global trials temporarily last week after an unexplained illness in a participant in Britain.

Clinical trials for the coronavirus vaccine being developed by AstraZeneca PLC and Oxford University resumed in Brazil on Monday after the country's health regulator got confirmation over the weekend that its British equivalent MHRA had approved the restart, a company representative said.
 

The Federal University of Sao Paulo, which is running the trials, said in a statement that 4,600 of the planned 5,000 volunteers have been vaccinated in Brazil without any of them reporting any serious health issues.
 

The volunteers have been recruited in Sao Paulo, Rio de Janeiro and Salvador in the northeastern state of Bahia where a hospital